Skip to contentNovartis Bioventures Ltd — NASTECH PHARMACEUTICAL CO INC insider: 137 transactions · InsiderLensNovartis Bioventures Ltd
- 10% owner at NASTECH PHARMACEUTICAL CO INC · on record since Aug 3, 2010
- 10% owner at Ra Pharmaceuticals, Inc. · on record since Oct 31, 2016
- 10% owner at CELADON GROUP INC · on record since Jan 29, 2014
- 10% owner at Akebia Therapeutics, Inc. · on record since Mar 27, 2014
- 10% owner at Tokai Pharmaceuticals Inc · on record since Sep 24, 2014
- 10% owner at PERFORMANCE TECHNOLOGIES INC \DE\ · on record since Feb 17, 2016
- 10% owner at Spyre Therapeutics, Inc. · on record since Apr 12, 2016
- 10% owner at ZETA ACQUISITION CORP II · on record since Mar 17, 2017
- 10% owner at AMERICAN CLAIMS EVALUATION INC · on record since Jun 28, 2017
- 10% owner at HEALTHCARE ACQUISITION CORP · on record since May 8, 2017
- 10% owner at ALTEON INC /DE · on record since Aug 23, 2017
- 10% owner at BICYCLE THERAPEUTICS PLC · on record since May 30, 2019
- 10% owner at Galera Therapeutics, Inc. · on record since Nov 12, 2019
- 10% owner at Akouos, Inc. · on record since Jun 25, 2020
- Former 10% Owner at Galera Therapeutics, Inc. · on record since Jun 22, 2020
- 10% owner at Forma Therapeutics Holdings, Inc., · on record since Jun 18, 2020
- Former 10% Owner at Akouos, Inc. · on record since Jul 2, 2020
Insider trading activity of Novartis Bioventures Ltd
- Transactions on record
- 137
- since Jan 21, 2011
- Open-market buys
- 4
- $9.6M
- Open-market sells
- 99
- $12.3M
- Companies traded
- 11
- last filing Jun 22, 2020
Figures computed from official regulatory filings — methodology.
Companies where Novartis Bioventures Ltd has traded
- Galera Therapeutics, Inc.8 tx · $8.6M · Jun 22, 2020
- BICYCLE THERAPEUTICS PLC7 tx · $2.4M · May 30, 2019
- ZETA ACQUISITION CORP II13 tx · $3.5M · Apr 15, 2019
- AMERICAN CLAIMS EVALUATION INC15 tx · $627.6K · Mar 15, 2019
- ALTEON INC /DE18 tx · $2.9M · Sep 14, 2018
- Spyre Therapeutics, Inc.3 tx · $944.8K · May 14, 2018
- Ra Pharmaceuticals, Inc.3 tx · $689.4K · Jun 6, 2017
- Tokai Pharmaceuticals Inc2 tx · $411.8K · Jun 18, 2015
- Akebia Therapeutics, Inc.5 tx · $3.1M · Mar 27, 2014
Track record of Novartis Bioventures Ltd
Statistical track record
Free- Open-market buys
- 6
- Last buy
- May 28, 2019
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Novartis Bioventures Ltd
Co-insiders of Novartis Bioventures Ltd
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
7 tx · $1.6M · Feb 6, 2014
BAKER FELIXALTEON INC /DE +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 22, 2020 | Sell | -1,001,312 | 8.25 USD | $8.3M | SEC |
| Jun 22, 2020 | Sell | -900 | 9.04 USD | $8.1K | SEC |
| Jun 9, 2020 | Sell | -8,652 | 9.66 USD | $83.6K | SEC |
| Jun 9, 2020 | Sell | -5,659 | 9.66 USD | $54.7K | SEC |
| Jun 9, 2020 | Sell | -7,000 | 9.38 USD | $65.7K | SEC |
| Jun 4, 2020 | Sell | -5,669 | 9.68 USD | $54.9K | SEC |
| Jun 4, 2020 | Sell | -5,208 | 9.78 USD | $50.9K | SEC |
| Jun 4, 2020 | Sell | -4,088 | 9.55 USD | $39K | SEC |
| May 30, 2019 | Other | 71,450 | — | — | SEC |
| May 30, 2019 | Other | 893,195 | — | — | SEC |
| May 30, 2019 | OtherD | -71,450 | — | — | SEC |
| May 30, 2019 | OtherD | -636,366 | — | — | SEC |
| May 30, 2019 | Buy | 168,630 | 14.00 USD | $2.4M | SEC |
| May 30, 2019 | OtherD | -893,195 | — | — | SEC |
| May 30, 2019 | Other | 636,366 | — | — | SEC |
| Apr 15, 2019 | Sell | -57,438 | 1.08 USD | $62K | SEC |
| Apr 15, 2019 | Sell | -28,794 | 0.99 USD | $28.5K | SEC |
| Apr 15, 2019 | Sell | -30,908 | 1.04 USD | $32.1K | SEC |
| Apr 10, 2019 | Sell | -140,230 | 1.09 USD | $152.9K | SEC |
| Apr 10, 2019 | Sell | -32,991 | 1.01 USD | $33.3K | SEC |
| Apr 10, 2019 | Sell | -27,525 | 1.02 USD | $28.1K | SEC |
| Apr 5, 2019 | Sell | -47,900 | 1.01 USD | $48.4K | SEC |
| Apr 5, 2019 | Sell | -24,661 | 1.02 USD | $25.2K | SEC |
| Apr 5, 2019 | Sell | -58,033 | 0.96 USD | $55.7K | SEC |
| Apr 2, 2019 | Sell | -63,100 | 0.91 USD | $57.4K | SEC |